128 related articles for article (PubMed ID: 24953217)
21. (E)-[125I]-5-AOIBV: a SPECT radioligand for the vesicular acetylcholine transporter.
Emond P; Mavel S; Zea-Ponce Y; Kassiou M; Garreau L; Bodard S; Drossard ML; Chalon S; Guilloteau D
Nucl Med Biol; 2007 Nov; 34(8):967-71. PubMed ID: 17998100
[TBL] [Abstract][Full Text] [Related]
22. The impact of dopamine D
Liu H; Luo Z; Gu J; Su Y; Flores H; Parsons SM; Zhou Y; Perlmutter JS; Tu Z
Eur J Pharm Sci; 2020 Feb; 143():105152. PubMed ID: 31740395
[TBL] [Abstract][Full Text] [Related]
23. Piperazine analog of vesamicol: in vitro and in vivo characterization for vesicular acetylcholine transporter.
Bando K; Naganuma T; Taguchi K; Ginoza Y; Tanaka Y; Koike K; Takatoku K
Synapse; 2000 Oct; 38(1):27-37. PubMed ID: 10941138
[TBL] [Abstract][Full Text] [Related]
24. Exploration of Sulfur-Containing Analogues for Imaging Vesicular Acetylcholine Transporter in the Brain.
Luo Z; Liu H; Jin H; Gu J; Yu Y; Kaneshige K; Perlmutter JS; Parsons SM; Tu Z
ChemMedChem; 2018 Sep; 13(18):1978-1987. PubMed ID: 30071131
[TBL] [Abstract][Full Text] [Related]
25. Chiral resolution of serial potent and selective σ
Yue X; Jin H; Luo Z; Liu H; Zhang X; McSpadden ED; Tian L; Flores HP; Perlmutter JS; Parsons SM; Tu Z
Bioorg Med Chem; 2017 Feb; 25(4):1533-1542. PubMed ID: 28129990
[TBL] [Abstract][Full Text] [Related]
26. The potential of (-)-o-[11C]methylvesamicol for diagnosing cholinergic deficit dementia.
Shiba K; Nishiyama S; Tsukada H; Ishiwata K; Kawamura K; Ogawa K; Mori H
Synapse; 2009 Feb; 63(2):167-71. PubMed ID: 19021207
[TBL] [Abstract][Full Text] [Related]
27. New systematically modified vesamicol analogs and their affinity and selectivity for the vesicular acetylcholine transporter - A critical examination of the lead structure.
Barthel C; Sorger D; Deuther-Conrad W; Scheunemann M; Schweiger S; Jäckel P; Roghani A; Steinbach J; Schüürmann G; Sabri O; Brust P; Wenzel B
Eur J Med Chem; 2015 Jul; 100():50-67. PubMed ID: 26071858
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological characterization of a promising F-18 PET tracer for vesicular acetylcholine transporter.
Tu Z; Zhang X; Jin H; Yue X; Padakanti PK; Yu L; Liu H; Flores HP; Kaneshige K; Parsons SM; Perlmutter JS
Bioorg Med Chem; 2015 Aug; 23(15):4699-4709. PubMed ID: 26138195
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and in vitro biological evaluation of carbonyl group-containing inhibitors of vesicular acetylcholine transporter.
Efange SM; Khare AB; von Hohenberg K; Mach RH; Parsons SM; Tu Z
J Med Chem; 2010 Apr; 53(7):2825-35. PubMed ID: 20218624
[TBL] [Abstract][Full Text] [Related]
30. 3D QSAR study, synthesis, and in vitro evaluation of (+)-5-FBVM as potential PET radioligand for the vesicular acetylcholine transporter (VAChT).
Kovac M; Mavel S; Deuther-Conrad W; Méheux N; Glöckner J; Wenzel B; Anderluh M; Brust P; Guilloteau D; Emond P
Bioorg Med Chem; 2010 Nov; 18(21):7659-67. PubMed ID: 20889347
[TBL] [Abstract][Full Text] [Related]
31. In Vivo and In Vitro Characteristics of Radiolabeled Vesamicol Analogs as the Vesicular Acetylcholine Transporter Imaging Agents.
Ogawa K; Shiba K
Contrast Media Mol Imaging; 2018; 2018():4535476. PubMed ID: 30008624
[TBL] [Abstract][Full Text] [Related]
32. Structural changes of benzylether derivatives of vesamicol and their influence on the binding selectivity to the vesicular acetylcholine transporter.
Wenzel B; Sorger D; Heinitz K; Scheunemann M; Schliebs R; Steinbach J; Sabri O
Eur J Med Chem; 2005 Dec; 40(12):1197-205. PubMed ID: 16095762
[TBL] [Abstract][Full Text] [Related]
33. Do spiroindolines have the potential to replace vesamicol as lead compound for the development of radioligands targeting the vesicular acetylcholine transporter?
Lindemann M; Deuther-Conrad W; Moldovan R; Sekhar KVGC; Brust P; Wenzel B
Bioorg Med Chem; 2017 Oct; 25(19):5107-5113. PubMed ID: 28347632
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and in vivo evaluation of 2 high-affinity 76Br-labeled sigma2-receptor ligands.
Rowland DJ; Tu Z; Xu J; Ponde D; Mach RH; Welch MJ
J Nucl Med; 2006 Jun; 47(6):1041-8. PubMed ID: 16741315
[TBL] [Abstract][Full Text] [Related]
35. Development of a novel radiobromine-labeled sigma-1 receptor imaging probe.
Ogawa K; Masuda R; Mizuno Y; Makino A; Kozaka T; Kitamura Y; Kiyono Y; Shiba K; Odani A
Nucl Med Biol; 2018 Jun; 61():28-35. PubMed ID: 29704822
[TBL] [Abstract][Full Text] [Related]
36. Decreased vesicular acetylcholine transporter related to memory deficits in epilepsy: A [
Wu XQ; Zhao YN; Ding J; Si Z; Cheng DF; Shi HC; Wang X
Epilepsia; 2018 Sep; 59(9):1655-1666. PubMed ID: 30126014
[TBL] [Abstract][Full Text] [Related]
37. In vivo imaging of human cholinergic nerve terminals with (-)-5-(18)F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses.
Petrou M; Frey KA; Kilbourn MR; Scott PJ; Raffel DM; Bohnen NI; Müller ML; Albin RL; Koeppe RA
J Nucl Med; 2014 Mar; 55(3):396-404. PubMed ID: 24481024
[TBL] [Abstract][Full Text] [Related]
38. In vivo evaluation in rats of [(18)F]1-(2-fluoroethyl)-4-[(4-cyanophenoxy)methyl]piperidine as a potential radiotracer for PET assessment of CNS sigma-1 receptors.
Waterhouse RN; Chang RC; Zhao J; Carambot PE
Nucl Med Biol; 2006 Feb; 33(2):211-5. PubMed ID: 16546675
[TBL] [Abstract][Full Text] [Related]
39. Positron emission tomography imaging of (2R,3R)-5-[(18)F]fluoroethoxybenzovesamicol in rat and monkey brain: a radioligand for the vesicular acetylcholine transporter.
Kilbourn MR; Hockley B; Lee L; Sherman P; Quesada C; Frey KA; Koeppe RA
Nucl Med Biol; 2009 Jul; 36(5):489-93. PubMed ID: 19520289
[TBL] [Abstract][Full Text] [Related]
40. Automated production of [¹⁸F]VAT suitable for clinical PET study of vesicular acetylcholine transporter.
Yue X; Bognar C; Zhang X; Gaehle GG; Moerlein SM; Perlmutter JS; Tu Z
Appl Radiat Isot; 2016 Jan; 107():40-46. PubMed ID: 26408913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
